News Focus
News Focus
Replies to #18117 on Biotech Values
icon url

DewDiligence

11/08/05 9:59 PM

#18122 RE: rfj1862 #18117

AMGN clearly thinks Denosumab has a marketing edge vs Zometa and Boniva, although I’m not sure exactly what it is.